Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We would like to congratulate Mr Simon Abram on his NIHR Doctoral Research Fellowship. Simon’s successful project proposal aims to address the unanswered questions and uncertainty surrounding the treatment of degenerative meniscal tears in the knee.

Meniscal tears are very common and annually, worldwide, over 2 million people undergo surgical treatment of meniscal tears which are associated with pain and other debilitating symptoms. The latest evidence, however, suggests that many of these patients do not benefit from surgery in comparison to non-surgical treatments, such as exercise therapy. Simon’s work aims to reduce the rate of unnecessary surgery being performing by developing an evidence-based treatment pathway for the NHS.

Commenting on his award, Simon said “I am extremely grateful to the NIHR for supporting this project which I believe has the potential to be highly beneficial to the health service and the large number of patients affected by this condition each year”.

Simon will undertake the project with the supervision of Prof Andrew Price, Prof David Beard, Associate Prof Sally Hopewell and Prof Andrew Judge.

 

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.